Global Boron-containing Compounds Drug Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Boron-containing Compounds Drug market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Boron-containing Compounds Drug Industry Forecast” looks at past sales and reviews total world Boron-containing Compounds Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Boron-containing Compounds Drug sales for 2024 through 2030. With Boron-containing Compounds Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Boron-containing Compounds Drug industry.
This Insight Report provides a comprehensive analysis of the global Boron-containing Compounds Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Boron-containing Compounds Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Boron-containing Compounds Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Boron-containing Compounds Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Boron-containing Compounds Drug.
United States market for Boron-containing Compounds Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Boron-containing Compounds Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Boron-containing Compounds Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Boron-containing Compounds Drug players cover Takeda Pharmaceutical, Janssen Pharmaceuticals, Pfizer, Hovione FarmaCiencia, Melinta Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Boron-containing Compounds Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Boron-containing Compounds Drug market?
What factors are driving Boron-containing Compounds Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Boron-containing Compounds Drug market opportunities vary by end market size?
How does Boron-containing Compounds Drug break out by Type, by Application?
The global Boron-containing Compounds Drug market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Boron-containing Compounds Drug Industry Forecast” looks at past sales and reviews total world Boron-containing Compounds Drug sales in 2023, providing a comprehensive analysis by region and market sector of projected Boron-containing Compounds Drug sales for 2024 through 2030. With Boron-containing Compounds Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Boron-containing Compounds Drug industry.
This Insight Report provides a comprehensive analysis of the global Boron-containing Compounds Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Boron-containing Compounds Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Boron-containing Compounds Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Boron-containing Compounds Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Boron-containing Compounds Drug.
United States market for Boron-containing Compounds Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Boron-containing Compounds Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Boron-containing Compounds Drug is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Boron-containing Compounds Drug players cover Takeda Pharmaceutical, Janssen Pharmaceuticals, Pfizer, Hovione FarmaCiencia, Melinta Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Boron-containing Compounds Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Bortezomib
- Tavaborole
- Crisaborole
- Vaborbactam-Meropenem
- Ixazomib
- Others
- Multiple Myeloma
- Toenail Fungal Infection
- Atopic Dermatitis
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda Pharmaceutical
- Janssen Pharmaceuticals
- Pfizer
- Hovione FarmaCiencia
- Melinta Therapeutics
- DC PHARMA
- Gao Jin Biology
- Neuboron
What is the 10-year outlook for the global Boron-containing Compounds Drug market?
What factors are driving Boron-containing Compounds Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Boron-containing Compounds Drug market opportunities vary by end market size?
How does Boron-containing Compounds Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Boron-containing Compounds Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Boron-containing Compounds Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Boron-containing Compounds Drug by Country/Region, 2019, 2023 & 2030
2.2 Boron-containing Compounds Drug Segment by Type
2.2.1 Bortezomib
2.2.2 Tavaborole
2.2.3 Crisaborole
2.2.4 Vaborbactam-Meropenem
2.2.5 Ixazomib
2.2.6 Others
2.3 Boron-containing Compounds Drug Sales by Type
2.3.1 Global Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Boron-containing Compounds Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Boron-containing Compounds Drug Sale Price by Type (2019-2024)
2.4 Boron-containing Compounds Drug Segment by Application
2.4.1 Multiple Myeloma
2.4.2 Toenail Fungal Infection
2.4.3 Atopic Dermatitis
2.4.4 Others
2.5 Boron-containing Compounds Drug Sales by Application
2.5.1 Global Boron-containing Compounds Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Boron-containing Compounds Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Boron-containing Compounds Drug Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Boron-containing Compounds Drug Breakdown Data by Company
3.1.1 Global Boron-containing Compounds Drug Annual Sales by Company (2019-2024)
3.1.2 Global Boron-containing Compounds Drug Sales Market Share by Company (2019-2024)
3.2 Global Boron-containing Compounds Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Boron-containing Compounds Drug Revenue by Company (2019-2024)
3.2.2 Global Boron-containing Compounds Drug Revenue Market Share by Company (2019-2024)
3.3 Global Boron-containing Compounds Drug Sale Price by Company
3.4 Key Manufacturers Boron-containing Compounds Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Boron-containing Compounds Drug Product Location Distribution
3.4.2 Players Boron-containing Compounds Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BORON-CONTAINING COMPOUNDS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Boron-containing Compounds Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Boron-containing Compounds Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Boron-containing Compounds Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Boron-containing Compounds Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Boron-containing Compounds Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Boron-containing Compounds Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Boron-containing Compounds Drug Sales Growth
4.4 APAC Boron-containing Compounds Drug Sales Growth
4.5 Europe Boron-containing Compounds Drug Sales Growth
4.6 Middle East & Africa Boron-containing Compounds Drug Sales Growth
5 AMERICAS
5.1 Americas Boron-containing Compounds Drug Sales by Country
5.1.1 Americas Boron-containing Compounds Drug Sales by Country (2019-2024)
5.1.2 Americas Boron-containing Compounds Drug Revenue by Country (2019-2024)
5.2 Americas Boron-containing Compounds Drug Sales by Type (2019-2024)
5.3 Americas Boron-containing Compounds Drug Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Boron-containing Compounds Drug Sales by Region
6.1.1 APAC Boron-containing Compounds Drug Sales by Region (2019-2024)
6.1.2 APAC Boron-containing Compounds Drug Revenue by Region (2019-2024)
6.2 APAC Boron-containing Compounds Drug Sales by Type (2019-2024)
6.3 APAC Boron-containing Compounds Drug Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Boron-containing Compounds Drug by Country
7.1.1 Europe Boron-containing Compounds Drug Sales by Country (2019-2024)
7.1.2 Europe Boron-containing Compounds Drug Revenue by Country (2019-2024)
7.2 Europe Boron-containing Compounds Drug Sales by Type (2019-2024)
7.3 Europe Boron-containing Compounds Drug Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Boron-containing Compounds Drug by Country
8.1.1 Middle East & Africa Boron-containing Compounds Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Boron-containing Compounds Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Boron-containing Compounds Drug Sales by Type (2019-2024)
8.3 Middle East & Africa Boron-containing Compounds Drug Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Boron-containing Compounds Drug
10.3 Manufacturing Process Analysis of Boron-containing Compounds Drug
10.4 Industry Chain Structure of Boron-containing Compounds Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Boron-containing Compounds Drug Distributors
11.3 Boron-containing Compounds Drug Customer
12 WORLD FORECAST REVIEW FOR BORON-CONTAINING COMPOUNDS DRUG BY GEOGRAPHIC REGION
12.1 Global Boron-containing Compounds Drug Market Size Forecast by Region
12.1.1 Global Boron-containing Compounds Drug Forecast by Region (2025-2030)
12.1.2 Global Boron-containing Compounds Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Boron-containing Compounds Drug Forecast by Type (2025-2030)
12.7 Global Boron-containing Compounds Drug Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Information
13.1.2 Takeda Pharmaceutical Boron-containing Compounds Drug Product Portfolios and Specifications
13.1.3 Takeda Pharmaceutical Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Pharmaceutical Main Business Overview
13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Janssen Pharmaceuticals
13.2.1 Janssen Pharmaceuticals Company Information
13.2.2 Janssen Pharmaceuticals Boron-containing Compounds Drug Product Portfolios and Specifications
13.2.3 Janssen Pharmaceuticals Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Janssen Pharmaceuticals Main Business Overview
13.2.5 Janssen Pharmaceuticals Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Boron-containing Compounds Drug Product Portfolios and Specifications
13.3.3 Pfizer Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Hovione FarmaCiencia
13.4.1 Hovione FarmaCiencia Company Information
13.4.2 Hovione FarmaCiencia Boron-containing Compounds Drug Product Portfolios and Specifications
13.4.3 Hovione FarmaCiencia Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hovione FarmaCiencia Main Business Overview
13.4.5 Hovione FarmaCiencia Latest Developments
13.5 Melinta Therapeutics
13.5.1 Melinta Therapeutics Company Information
13.5.2 Melinta Therapeutics Boron-containing Compounds Drug Product Portfolios and Specifications
13.5.3 Melinta Therapeutics Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Melinta Therapeutics Main Business Overview
13.5.5 Melinta Therapeutics Latest Developments
13.6 DC PHARMA
13.6.1 DC PHARMA Company Information
13.6.2 DC PHARMA Boron-containing Compounds Drug Product Portfolios and Specifications
13.6.3 DC PHARMA Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 DC PHARMA Main Business Overview
13.6.5 DC PHARMA Latest Developments
13.7 Gao Jin Biology
13.7.1 Gao Jin Biology Company Information
13.7.2 Gao Jin Biology Boron-containing Compounds Drug Product Portfolios and Specifications
13.7.3 Gao Jin Biology Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gao Jin Biology Main Business Overview
13.7.5 Gao Jin Biology Latest Developments
13.8 Neuboron
13.8.1 Neuboron Company Information
13.8.2 Neuboron Boron-containing Compounds Drug Product Portfolios and Specifications
13.8.3 Neuboron Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Neuboron Main Business Overview
13.8.5 Neuboron Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Boron-containing Compounds Drug Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Boron-containing Compounds Drug by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Boron-containing Compounds Drug by Country/Region, 2019, 2023 & 2030
2.2 Boron-containing Compounds Drug Segment by Type
2.2.1 Bortezomib
2.2.2 Tavaborole
2.2.3 Crisaborole
2.2.4 Vaborbactam-Meropenem
2.2.5 Ixazomib
2.2.6 Others
2.3 Boron-containing Compounds Drug Sales by Type
2.3.1 Global Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
2.3.2 Global Boron-containing Compounds Drug Revenue and Market Share by Type (2019-2024)
2.3.3 Global Boron-containing Compounds Drug Sale Price by Type (2019-2024)
2.4 Boron-containing Compounds Drug Segment by Application
2.4.1 Multiple Myeloma
2.4.2 Toenail Fungal Infection
2.4.3 Atopic Dermatitis
2.4.4 Others
2.5 Boron-containing Compounds Drug Sales by Application
2.5.1 Global Boron-containing Compounds Drug Sale Market Share by Application (2019-2024)
2.5.2 Global Boron-containing Compounds Drug Revenue and Market Share by Application (2019-2024)
2.5.3 Global Boron-containing Compounds Drug Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Boron-containing Compounds Drug Breakdown Data by Company
3.1.1 Global Boron-containing Compounds Drug Annual Sales by Company (2019-2024)
3.1.2 Global Boron-containing Compounds Drug Sales Market Share by Company (2019-2024)
3.2 Global Boron-containing Compounds Drug Annual Revenue by Company (2019-2024)
3.2.1 Global Boron-containing Compounds Drug Revenue by Company (2019-2024)
3.2.2 Global Boron-containing Compounds Drug Revenue Market Share by Company (2019-2024)
3.3 Global Boron-containing Compounds Drug Sale Price by Company
3.4 Key Manufacturers Boron-containing Compounds Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Boron-containing Compounds Drug Product Location Distribution
3.4.2 Players Boron-containing Compounds Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BORON-CONTAINING COMPOUNDS DRUG BY GEOGRAPHIC REGION
4.1 World Historic Boron-containing Compounds Drug Market Size by Geographic Region (2019-2024)
4.1.1 Global Boron-containing Compounds Drug Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Boron-containing Compounds Drug Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Boron-containing Compounds Drug Market Size by Country/Region (2019-2024)
4.2.1 Global Boron-containing Compounds Drug Annual Sales by Country/Region (2019-2024)
4.2.2 Global Boron-containing Compounds Drug Annual Revenue by Country/Region (2019-2024)
4.3 Americas Boron-containing Compounds Drug Sales Growth
4.4 APAC Boron-containing Compounds Drug Sales Growth
4.5 Europe Boron-containing Compounds Drug Sales Growth
4.6 Middle East & Africa Boron-containing Compounds Drug Sales Growth
5 AMERICAS
5.1 Americas Boron-containing Compounds Drug Sales by Country
5.1.1 Americas Boron-containing Compounds Drug Sales by Country (2019-2024)
5.1.2 Americas Boron-containing Compounds Drug Revenue by Country (2019-2024)
5.2 Americas Boron-containing Compounds Drug Sales by Type (2019-2024)
5.3 Americas Boron-containing Compounds Drug Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Boron-containing Compounds Drug Sales by Region
6.1.1 APAC Boron-containing Compounds Drug Sales by Region (2019-2024)
6.1.2 APAC Boron-containing Compounds Drug Revenue by Region (2019-2024)
6.2 APAC Boron-containing Compounds Drug Sales by Type (2019-2024)
6.3 APAC Boron-containing Compounds Drug Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Boron-containing Compounds Drug by Country
7.1.1 Europe Boron-containing Compounds Drug Sales by Country (2019-2024)
7.1.2 Europe Boron-containing Compounds Drug Revenue by Country (2019-2024)
7.2 Europe Boron-containing Compounds Drug Sales by Type (2019-2024)
7.3 Europe Boron-containing Compounds Drug Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Boron-containing Compounds Drug by Country
8.1.1 Middle East & Africa Boron-containing Compounds Drug Sales by Country (2019-2024)
8.1.2 Middle East & Africa Boron-containing Compounds Drug Revenue by Country (2019-2024)
8.2 Middle East & Africa Boron-containing Compounds Drug Sales by Type (2019-2024)
8.3 Middle East & Africa Boron-containing Compounds Drug Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Boron-containing Compounds Drug
10.3 Manufacturing Process Analysis of Boron-containing Compounds Drug
10.4 Industry Chain Structure of Boron-containing Compounds Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Boron-containing Compounds Drug Distributors
11.3 Boron-containing Compounds Drug Customer
12 WORLD FORECAST REVIEW FOR BORON-CONTAINING COMPOUNDS DRUG BY GEOGRAPHIC REGION
12.1 Global Boron-containing Compounds Drug Market Size Forecast by Region
12.1.1 Global Boron-containing Compounds Drug Forecast by Region (2025-2030)
12.1.2 Global Boron-containing Compounds Drug Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Boron-containing Compounds Drug Forecast by Type (2025-2030)
12.7 Global Boron-containing Compounds Drug Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Information
13.1.2 Takeda Pharmaceutical Boron-containing Compounds Drug Product Portfolios and Specifications
13.1.3 Takeda Pharmaceutical Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Takeda Pharmaceutical Main Business Overview
13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Janssen Pharmaceuticals
13.2.1 Janssen Pharmaceuticals Company Information
13.2.2 Janssen Pharmaceuticals Boron-containing Compounds Drug Product Portfolios and Specifications
13.2.3 Janssen Pharmaceuticals Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Janssen Pharmaceuticals Main Business Overview
13.2.5 Janssen Pharmaceuticals Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Boron-containing Compounds Drug Product Portfolios and Specifications
13.3.3 Pfizer Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Hovione FarmaCiencia
13.4.1 Hovione FarmaCiencia Company Information
13.4.2 Hovione FarmaCiencia Boron-containing Compounds Drug Product Portfolios and Specifications
13.4.3 Hovione FarmaCiencia Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Hovione FarmaCiencia Main Business Overview
13.4.5 Hovione FarmaCiencia Latest Developments
13.5 Melinta Therapeutics
13.5.1 Melinta Therapeutics Company Information
13.5.2 Melinta Therapeutics Boron-containing Compounds Drug Product Portfolios and Specifications
13.5.3 Melinta Therapeutics Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Melinta Therapeutics Main Business Overview
13.5.5 Melinta Therapeutics Latest Developments
13.6 DC PHARMA
13.6.1 DC PHARMA Company Information
13.6.2 DC PHARMA Boron-containing Compounds Drug Product Portfolios and Specifications
13.6.3 DC PHARMA Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 DC PHARMA Main Business Overview
13.6.5 DC PHARMA Latest Developments
13.7 Gao Jin Biology
13.7.1 Gao Jin Biology Company Information
13.7.2 Gao Jin Biology Boron-containing Compounds Drug Product Portfolios and Specifications
13.7.3 Gao Jin Biology Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gao Jin Biology Main Business Overview
13.7.5 Gao Jin Biology Latest Developments
13.8 Neuboron
13.8.1 Neuboron Company Information
13.8.2 Neuboron Boron-containing Compounds Drug Product Portfolios and Specifications
13.8.3 Neuboron Boron-containing Compounds Drug Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Neuboron Main Business Overview
13.8.5 Neuboron Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Boron-containing Compounds Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Boron-containing Compounds Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Bortezomib
Table 4. Major Players of Tavaborole
Table 5. Major Players of Crisaborole
Table 6. Major Players of Vaborbactam-Meropenem
Table 7. Major Players of Ixazomib
Table 8. Major Players of Others
Table 9. Global Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 10. Global Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Table 11. Global Boron-containing Compounds Drug Revenue by Type (2019-2024) & ($ million)
Table 12. Global Boron-containing Compounds Drug Revenue Market Share by Type (2019-2024)
Table 13. Global Boron-containing Compounds Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Boron-containing Compounds Drug Sale by Application (2019-2024) & (Units)
Table 15. Global Boron-containing Compounds Drug Sale Market Share by Application (2019-2024)
Table 16. Global Boron-containing Compounds Drug Revenue by Application (2019-2024) & ($ million)
Table 17. Global Boron-containing Compounds Drug Revenue Market Share by Application (2019-2024)
Table 18. Global Boron-containing Compounds Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Boron-containing Compounds Drug Sales by Company (2019-2024) & (Units)
Table 20. Global Boron-containing Compounds Drug Sales Market Share by Company (2019-2024)
Table 21. Global Boron-containing Compounds Drug Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Boron-containing Compounds Drug Revenue Market Share by Company (2019-2024)
Table 23. Global Boron-containing Compounds Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Boron-containing Compounds Drug Producing Area Distribution and Sales Area
Table 25. Players Boron-containing Compounds Drug Products Offered
Table 26. Boron-containing Compounds Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Boron-containing Compounds Drug Sales by Geographic Region (2019-2024) & (Units)
Table 30. Global Boron-containing Compounds Drug Sales Market Share Geographic Region (2019-2024)
Table 31. Global Boron-containing Compounds Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Boron-containing Compounds Drug Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Boron-containing Compounds Drug Sales by Country/Region (2019-2024) & (Units)
Table 34. Global Boron-containing Compounds Drug Sales Market Share by Country/Region (2019-2024)
Table 35. Global Boron-containing Compounds Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Boron-containing Compounds Drug Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
Table 38. Americas Boron-containing Compounds Drug Sales Market Share by Country (2019-2024)
Table 39. Americas Boron-containing Compounds Drug Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 41. Americas Boron-containing Compounds Drug Sales by Application (2019-2024) & (Units)
Table 42. APAC Boron-containing Compounds Drug Sales by Region (2019-2024) & (Units)
Table 43. APAC Boron-containing Compounds Drug Sales Market Share by Region (2019-2024)
Table 44. APAC Boron-containing Compounds Drug Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 46. APAC Boron-containing Compounds Drug Sales by Application (2019-2024) & (Units)
Table 47. Europe Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
Table 48. Europe Boron-containing Compounds Drug Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 50. Europe Boron-containing Compounds Drug Sales by Application (2019-2024) & (Units)
Table 51. Middle East & Africa Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
Table 52. Middle East & Africa Boron-containing Compounds Drug Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 54. Middle East & Africa Boron-containing Compounds Drug Sales by Application (2019-2024) & (Units)
Table 55. Key Market Drivers & Growth Opportunities of Boron-containing Compounds Drug
Table 56. Key Market Challenges & Risks of Boron-containing Compounds Drug
Table 57. Key Industry Trends of Boron-containing Compounds Drug
Table 58. Boron-containing Compounds Drug Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Boron-containing Compounds Drug Distributors List
Table 61. Boron-containing Compounds Drug Customer List
Table 62. Global Boron-containing Compounds Drug Sales Forecast by Region (2025-2030) & (Units)
Table 63. Global Boron-containing Compounds Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Americas Boron-containing Compounds Drug Sales Forecast by Country (2025-2030) & (Units)
Table 65. Americas Boron-containing Compounds Drug Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. APAC Boron-containing Compounds Drug Sales Forecast by Region (2025-2030) & (Units)
Table 67. APAC Boron-containing Compounds Drug Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Europe Boron-containing Compounds Drug Sales Forecast by Country (2025-2030) & (Units)
Table 69. Europe Boron-containing Compounds Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Boron-containing Compounds Drug Sales Forecast by Country (2025-2030) & (Units)
Table 71. Middle East & Africa Boron-containing Compounds Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Global Boron-containing Compounds Drug Sales Forecast by Type (2025-2030) & (Units)
Table 73. Global Boron-containing Compounds Drug Revenue Forecast by Type (2025-2030) & ($ millions)
Table 74. Global Boron-containing Compounds Drug Sales Forecast by Application (2025-2030) & (Units)
Table 75. Global Boron-containing Compounds Drug Revenue Forecast by Application (2025-2030) & ($ millions)
Table 76. Takeda Pharmaceutical Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 77. Takeda Pharmaceutical Boron-containing Compounds Drug Product Portfolios and Specifications
Table 78. Takeda Pharmaceutical Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. Takeda Pharmaceutical Main Business
Table 80. Takeda Pharmaceutical Latest Developments
Table 81. Janssen Pharmaceuticals Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Janssen Pharmaceuticals Boron-containing Compounds Drug Product Portfolios and Specifications
Table 83. Janssen Pharmaceuticals Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Janssen Pharmaceuticals Main Business
Table 85. Janssen Pharmaceuticals Latest Developments
Table 86. Pfizer Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Boron-containing Compounds Drug Product Portfolios and Specifications
Table 88. Pfizer Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Hovione FarmaCiencia Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Hovione FarmaCiencia Boron-containing Compounds Drug Product Portfolios and Specifications
Table 93. Hovione FarmaCiencia Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Hovione FarmaCiencia Main Business
Table 95. Hovione FarmaCiencia Latest Developments
Table 96. Melinta Therapeutics Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Melinta Therapeutics Boron-containing Compounds Drug Product Portfolios and Specifications
Table 98. Melinta Therapeutics Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Melinta Therapeutics Main Business
Table 100. Melinta Therapeutics Latest Developments
Table 101. DC PHARMA Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. DC PHARMA Boron-containing Compounds Drug Product Portfolios and Specifications
Table 103. DC PHARMA Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. DC PHARMA Main Business
Table 105. DC PHARMA Latest Developments
Table 106. Gao Jin Biology Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Gao Jin Biology Boron-containing Compounds Drug Product Portfolios and Specifications
Table 108. Gao Jin Biology Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Gao Jin Biology Main Business
Table 110. Gao Jin Biology Latest Developments
Table 111. Neuboron Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Neuboron Boron-containing Compounds Drug Product Portfolios and Specifications
Table 113. Neuboron Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Neuboron Main Business
Table 115. Neuboron Latest Developments
Table 1. Boron-containing Compounds Drug Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Boron-containing Compounds Drug Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Bortezomib
Table 4. Major Players of Tavaborole
Table 5. Major Players of Crisaborole
Table 6. Major Players of Vaborbactam-Meropenem
Table 7. Major Players of Ixazomib
Table 8. Major Players of Others
Table 9. Global Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 10. Global Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Table 11. Global Boron-containing Compounds Drug Revenue by Type (2019-2024) & ($ million)
Table 12. Global Boron-containing Compounds Drug Revenue Market Share by Type (2019-2024)
Table 13. Global Boron-containing Compounds Drug Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Boron-containing Compounds Drug Sale by Application (2019-2024) & (Units)
Table 15. Global Boron-containing Compounds Drug Sale Market Share by Application (2019-2024)
Table 16. Global Boron-containing Compounds Drug Revenue by Application (2019-2024) & ($ million)
Table 17. Global Boron-containing Compounds Drug Revenue Market Share by Application (2019-2024)
Table 18. Global Boron-containing Compounds Drug Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Boron-containing Compounds Drug Sales by Company (2019-2024) & (Units)
Table 20. Global Boron-containing Compounds Drug Sales Market Share by Company (2019-2024)
Table 21. Global Boron-containing Compounds Drug Revenue by Company (2019-2024) & ($ millions)
Table 22. Global Boron-containing Compounds Drug Revenue Market Share by Company (2019-2024)
Table 23. Global Boron-containing Compounds Drug Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Boron-containing Compounds Drug Producing Area Distribution and Sales Area
Table 25. Players Boron-containing Compounds Drug Products Offered
Table 26. Boron-containing Compounds Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Market M&A Activity & Strategy
Table 29. Global Boron-containing Compounds Drug Sales by Geographic Region (2019-2024) & (Units)
Table 30. Global Boron-containing Compounds Drug Sales Market Share Geographic Region (2019-2024)
Table 31. Global Boron-containing Compounds Drug Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Boron-containing Compounds Drug Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Boron-containing Compounds Drug Sales by Country/Region (2019-2024) & (Units)
Table 34. Global Boron-containing Compounds Drug Sales Market Share by Country/Region (2019-2024)
Table 35. Global Boron-containing Compounds Drug Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Boron-containing Compounds Drug Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
Table 38. Americas Boron-containing Compounds Drug Sales Market Share by Country (2019-2024)
Table 39. Americas Boron-containing Compounds Drug Revenue by Country (2019-2024) & ($ millions)
Table 40. Americas Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 41. Americas Boron-containing Compounds Drug Sales by Application (2019-2024) & (Units)
Table 42. APAC Boron-containing Compounds Drug Sales by Region (2019-2024) & (Units)
Table 43. APAC Boron-containing Compounds Drug Sales Market Share by Region (2019-2024)
Table 44. APAC Boron-containing Compounds Drug Revenue by Region (2019-2024) & ($ millions)
Table 45. APAC Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 46. APAC Boron-containing Compounds Drug Sales by Application (2019-2024) & (Units)
Table 47. Europe Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
Table 48. Europe Boron-containing Compounds Drug Revenue by Country (2019-2024) & ($ millions)
Table 49. Europe Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 50. Europe Boron-containing Compounds Drug Sales by Application (2019-2024) & (Units)
Table 51. Middle East & Africa Boron-containing Compounds Drug Sales by Country (2019-2024) & (Units)
Table 52. Middle East & Africa Boron-containing Compounds Drug Revenue Market Share by Country (2019-2024)
Table 53. Middle East & Africa Boron-containing Compounds Drug Sales by Type (2019-2024) & (Units)
Table 54. Middle East & Africa Boron-containing Compounds Drug Sales by Application (2019-2024) & (Units)
Table 55. Key Market Drivers & Growth Opportunities of Boron-containing Compounds Drug
Table 56. Key Market Challenges & Risks of Boron-containing Compounds Drug
Table 57. Key Industry Trends of Boron-containing Compounds Drug
Table 58. Boron-containing Compounds Drug Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Boron-containing Compounds Drug Distributors List
Table 61. Boron-containing Compounds Drug Customer List
Table 62. Global Boron-containing Compounds Drug Sales Forecast by Region (2025-2030) & (Units)
Table 63. Global Boron-containing Compounds Drug Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Americas Boron-containing Compounds Drug Sales Forecast by Country (2025-2030) & (Units)
Table 65. Americas Boron-containing Compounds Drug Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. APAC Boron-containing Compounds Drug Sales Forecast by Region (2025-2030) & (Units)
Table 67. APAC Boron-containing Compounds Drug Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Europe Boron-containing Compounds Drug Sales Forecast by Country (2025-2030) & (Units)
Table 69. Europe Boron-containing Compounds Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. Middle East & Africa Boron-containing Compounds Drug Sales Forecast by Country (2025-2030) & (Units)
Table 71. Middle East & Africa Boron-containing Compounds Drug Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Global Boron-containing Compounds Drug Sales Forecast by Type (2025-2030) & (Units)
Table 73. Global Boron-containing Compounds Drug Revenue Forecast by Type (2025-2030) & ($ millions)
Table 74. Global Boron-containing Compounds Drug Sales Forecast by Application (2025-2030) & (Units)
Table 75. Global Boron-containing Compounds Drug Revenue Forecast by Application (2025-2030) & ($ millions)
Table 76. Takeda Pharmaceutical Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 77. Takeda Pharmaceutical Boron-containing Compounds Drug Product Portfolios and Specifications
Table 78. Takeda Pharmaceutical Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 79. Takeda Pharmaceutical Main Business
Table 80. Takeda Pharmaceutical Latest Developments
Table 81. Janssen Pharmaceuticals Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Janssen Pharmaceuticals Boron-containing Compounds Drug Product Portfolios and Specifications
Table 83. Janssen Pharmaceuticals Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 84. Janssen Pharmaceuticals Main Business
Table 85. Janssen Pharmaceuticals Latest Developments
Table 86. Pfizer Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Pfizer Boron-containing Compounds Drug Product Portfolios and Specifications
Table 88. Pfizer Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 89. Pfizer Main Business
Table 90. Pfizer Latest Developments
Table 91. Hovione FarmaCiencia Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Hovione FarmaCiencia Boron-containing Compounds Drug Product Portfolios and Specifications
Table 93. Hovione FarmaCiencia Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 94. Hovione FarmaCiencia Main Business
Table 95. Hovione FarmaCiencia Latest Developments
Table 96. Melinta Therapeutics Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Melinta Therapeutics Boron-containing Compounds Drug Product Portfolios and Specifications
Table 98. Melinta Therapeutics Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 99. Melinta Therapeutics Main Business
Table 100. Melinta Therapeutics Latest Developments
Table 101. DC PHARMA Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. DC PHARMA Boron-containing Compounds Drug Product Portfolios and Specifications
Table 103. DC PHARMA Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 104. DC PHARMA Main Business
Table 105. DC PHARMA Latest Developments
Table 106. Gao Jin Biology Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Gao Jin Biology Boron-containing Compounds Drug Product Portfolios and Specifications
Table 108. Gao Jin Biology Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 109. Gao Jin Biology Main Business
Table 110. Gao Jin Biology Latest Developments
Table 111. Neuboron Basic Information, Boron-containing Compounds Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. Neuboron Boron-containing Compounds Drug Product Portfolios and Specifications
Table 113. Neuboron Boron-containing Compounds Drug Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 114. Neuboron Main Business
Table 115. Neuboron Latest Developments
LIST OF FIGURES
Figure 1. Picture of Boron-containing Compounds Drug
Figure 2. Boron-containing Compounds Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Boron-containing Compounds Drug Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Boron-containing Compounds Drug Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Boron-containing Compounds Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Boron-containing Compounds Drug Sales Market Share by Country/Region (2023)
Figure 10. Boron-containing Compounds Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Bortezomib
Figure 12. Product Picture of Tavaborole
Figure 13. Product Picture of Crisaborole
Figure 14. Product Picture of Vaborbactam-Meropenem
Figure 15. Product Picture of Ixazomib
Figure 16. Product Picture of Others
Figure 17. Global Boron-containing Compounds Drug Sales Market Share by Type in 2023
Figure 18. Global Boron-containing Compounds Drug Revenue Market Share by Type (2019-2024)
Figure 19. Boron-containing Compounds Drug Consumed in Multiple Myeloma
Figure 20. Global Boron-containing Compounds Drug Market: Multiple Myeloma (2019-2024) & (Units)
Figure 21. Boron-containing Compounds Drug Consumed in Toenail Fungal Infection
Figure 22. Global Boron-containing Compounds Drug Market: Toenail Fungal Infection (2019-2024) & (Units)
Figure 23. Boron-containing Compounds Drug Consumed in Atopic Dermatitis
Figure 24. Global Boron-containing Compounds Drug Market: Atopic Dermatitis (2019-2024) & (Units)
Figure 25. Boron-containing Compounds Drug Consumed in Others
Figure 26. Global Boron-containing Compounds Drug Market: Others (2019-2024) & (Units)
Figure 27. Global Boron-containing Compounds Drug Sale Market Share by Application (2023)
Figure 28. Global Boron-containing Compounds Drug Revenue Market Share by Application in 2023
Figure 29. Boron-containing Compounds Drug Sales by Company in 2023 (Units)
Figure 30. Global Boron-containing Compounds Drug Sales Market Share by Company in 2023
Figure 31. Boron-containing Compounds Drug Revenue by Company in 2023 ($ millions)
Figure 32. Global Boron-containing Compounds Drug Revenue Market Share by Company in 2023
Figure 33. Global Boron-containing Compounds Drug Sales Market Share by Geographic Region (2019-2024)
Figure 34. Global Boron-containing Compounds Drug Revenue Market Share by Geographic Region in 2023
Figure 35. Americas Boron-containing Compounds Drug Sales 2019-2024 (Units)
Figure 36. Americas Boron-containing Compounds Drug Revenue 2019-2024 ($ millions)
Figure 37. APAC Boron-containing Compounds Drug Sales 2019-2024 (Units)
Figure 38. APAC Boron-containing Compounds Drug Revenue 2019-2024 ($ millions)
Figure 39. Europe Boron-containing Compounds Drug Sales 2019-2024 (Units)
Figure 40. Europe Boron-containing Compounds Drug Revenue 2019-2024 ($ millions)
Figure 41. Middle East & Africa Boron-containing Compounds Drug Sales 2019-2024 (Units)
Figure 42. Middle East & Africa Boron-containing Compounds Drug Revenue 2019-2024 ($ millions)
Figure 43. Americas Boron-containing Compounds Drug Sales Market Share by Country in 2023
Figure 44. Americas Boron-containing Compounds Drug Revenue Market Share by Country (2019-2024)
Figure 45. Americas Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Figure 46. Americas Boron-containing Compounds Drug Sales Market Share by Application (2019-2024)
Figure 47. United States Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 48. Canada Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 49. Mexico Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 50. Brazil Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 51. APAC Boron-containing Compounds Drug Sales Market Share by Region in 2023
Figure 52. APAC Boron-containing Compounds Drug Revenue Market Share by Region (2019-2024)
Figure 53. APAC Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Figure 54. APAC Boron-containing Compounds Drug Sales Market Share by Application (2019-2024)
Figure 55. China Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 56. Japan Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 57. South Korea Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 58. Southeast Asia Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 59. India Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 60. Australia Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 61. China Taiwan Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 62. Europe Boron-containing Compounds Drug Sales Market Share by Country in 2023
Figure 63. Europe Boron-containing Compounds Drug Revenue Market Share by Country (2019-2024)
Figure 64. Europe Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Figure 65. Europe Boron-containing Compounds Drug Sales Market Share by Application (2019-2024)
Figure 66. Germany Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 67. France Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 68. UK Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 69. Italy Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 70. Russia Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 71. Middle East & Africa Boron-containing Compounds Drug Sales Market Share by Country (2019-2024)
Figure 72. Middle East & Africa Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Boron-containing Compounds Drug Sales Market Share by Application (2019-2024)
Figure 74. Egypt Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 75. South Africa Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 76. Israel Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 77. Turkey Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 78. GCC Countries Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Boron-containing Compounds Drug in 2023
Figure 80. Manufacturing Process Analysis of Boron-containing Compounds Drug
Figure 81. Industry Chain Structure of Boron-containing Compounds Drug
Figure 82. Channels of Distribution
Figure 83. Global Boron-containing Compounds Drug Sales Market Forecast by Region (2025-2030)
Figure 84. Global Boron-containing Compounds Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Boron-containing Compounds Drug Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Boron-containing Compounds Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Boron-containing Compounds Drug Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Boron-containing Compounds Drug Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Boron-containing Compounds Drug
Figure 2. Boron-containing Compounds Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Boron-containing Compounds Drug Sales Growth Rate 2019-2030 (Units)
Figure 7. Global Boron-containing Compounds Drug Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Boron-containing Compounds Drug Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Boron-containing Compounds Drug Sales Market Share by Country/Region (2023)
Figure 10. Boron-containing Compounds Drug Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Bortezomib
Figure 12. Product Picture of Tavaborole
Figure 13. Product Picture of Crisaborole
Figure 14. Product Picture of Vaborbactam-Meropenem
Figure 15. Product Picture of Ixazomib
Figure 16. Product Picture of Others
Figure 17. Global Boron-containing Compounds Drug Sales Market Share by Type in 2023
Figure 18. Global Boron-containing Compounds Drug Revenue Market Share by Type (2019-2024)
Figure 19. Boron-containing Compounds Drug Consumed in Multiple Myeloma
Figure 20. Global Boron-containing Compounds Drug Market: Multiple Myeloma (2019-2024) & (Units)
Figure 21. Boron-containing Compounds Drug Consumed in Toenail Fungal Infection
Figure 22. Global Boron-containing Compounds Drug Market: Toenail Fungal Infection (2019-2024) & (Units)
Figure 23. Boron-containing Compounds Drug Consumed in Atopic Dermatitis
Figure 24. Global Boron-containing Compounds Drug Market: Atopic Dermatitis (2019-2024) & (Units)
Figure 25. Boron-containing Compounds Drug Consumed in Others
Figure 26. Global Boron-containing Compounds Drug Market: Others (2019-2024) & (Units)
Figure 27. Global Boron-containing Compounds Drug Sale Market Share by Application (2023)
Figure 28. Global Boron-containing Compounds Drug Revenue Market Share by Application in 2023
Figure 29. Boron-containing Compounds Drug Sales by Company in 2023 (Units)
Figure 30. Global Boron-containing Compounds Drug Sales Market Share by Company in 2023
Figure 31. Boron-containing Compounds Drug Revenue by Company in 2023 ($ millions)
Figure 32. Global Boron-containing Compounds Drug Revenue Market Share by Company in 2023
Figure 33. Global Boron-containing Compounds Drug Sales Market Share by Geographic Region (2019-2024)
Figure 34. Global Boron-containing Compounds Drug Revenue Market Share by Geographic Region in 2023
Figure 35. Americas Boron-containing Compounds Drug Sales 2019-2024 (Units)
Figure 36. Americas Boron-containing Compounds Drug Revenue 2019-2024 ($ millions)
Figure 37. APAC Boron-containing Compounds Drug Sales 2019-2024 (Units)
Figure 38. APAC Boron-containing Compounds Drug Revenue 2019-2024 ($ millions)
Figure 39. Europe Boron-containing Compounds Drug Sales 2019-2024 (Units)
Figure 40. Europe Boron-containing Compounds Drug Revenue 2019-2024 ($ millions)
Figure 41. Middle East & Africa Boron-containing Compounds Drug Sales 2019-2024 (Units)
Figure 42. Middle East & Africa Boron-containing Compounds Drug Revenue 2019-2024 ($ millions)
Figure 43. Americas Boron-containing Compounds Drug Sales Market Share by Country in 2023
Figure 44. Americas Boron-containing Compounds Drug Revenue Market Share by Country (2019-2024)
Figure 45. Americas Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Figure 46. Americas Boron-containing Compounds Drug Sales Market Share by Application (2019-2024)
Figure 47. United States Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 48. Canada Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 49. Mexico Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 50. Brazil Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 51. APAC Boron-containing Compounds Drug Sales Market Share by Region in 2023
Figure 52. APAC Boron-containing Compounds Drug Revenue Market Share by Region (2019-2024)
Figure 53. APAC Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Figure 54. APAC Boron-containing Compounds Drug Sales Market Share by Application (2019-2024)
Figure 55. China Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 56. Japan Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 57. South Korea Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 58. Southeast Asia Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 59. India Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 60. Australia Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 61. China Taiwan Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 62. Europe Boron-containing Compounds Drug Sales Market Share by Country in 2023
Figure 63. Europe Boron-containing Compounds Drug Revenue Market Share by Country (2019-2024)
Figure 64. Europe Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Figure 65. Europe Boron-containing Compounds Drug Sales Market Share by Application (2019-2024)
Figure 66. Germany Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 67. France Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 68. UK Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 69. Italy Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 70. Russia Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 71. Middle East & Africa Boron-containing Compounds Drug Sales Market Share by Country (2019-2024)
Figure 72. Middle East & Africa Boron-containing Compounds Drug Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Boron-containing Compounds Drug Sales Market Share by Application (2019-2024)
Figure 74. Egypt Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 75. South Africa Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 76. Israel Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 77. Turkey Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 78. GCC Countries Boron-containing Compounds Drug Revenue Growth 2019-2024 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Boron-containing Compounds Drug in 2023
Figure 80. Manufacturing Process Analysis of Boron-containing Compounds Drug
Figure 81. Industry Chain Structure of Boron-containing Compounds Drug
Figure 82. Channels of Distribution
Figure 83. Global Boron-containing Compounds Drug Sales Market Forecast by Region (2025-2030)
Figure 84. Global Boron-containing Compounds Drug Revenue Market Share Forecast by Region (2025-2030)
Figure 85. Global Boron-containing Compounds Drug Sales Market Share Forecast by Type (2025-2030)
Figure 86. Global Boron-containing Compounds Drug Revenue Market Share Forecast by Type (2025-2030)
Figure 87. Global Boron-containing Compounds Drug Sales Market Share Forecast by Application (2025-2030)
Figure 88. Global Boron-containing Compounds Drug Revenue Market Share Forecast by Application (2025-2030)
